182 related articles for article (PubMed ID: 24736739)
1. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
Jin B; Dong Y; Zhang X; Wang H; Han B
PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the association between XPC Lys939Gln polymorphism and cutaneous melanoma risk.
Zhou L; Lu Y; Yang G; Wu J
Tumour Biol; 2014 Feb; 35(2):1427-32. PubMed ID: 24277375
[TBL] [Abstract][Full Text] [Related]
3. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
Zhu ML; Hua RX; Zheng L
Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
[TBL] [Abstract][Full Text] [Related]
4. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
[TBL] [Abstract][Full Text] [Related]
5. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
[TBL] [Abstract][Full Text] [Related]
6. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
[TBL] [Abstract][Full Text] [Related]
8. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
[TBL] [Abstract][Full Text] [Related]
9. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
[TBL] [Abstract][Full Text] [Related]
10. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
[TBL] [Abstract][Full Text] [Related]
11. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
Zhang Y; Wang X; Zhang W; Gong S
Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.
Liu C; Yin Q; Hu J; Li L; Zhang Y; Wang Y
Tumour Biol; 2013 Apr; 34(2):1205-13. PubMed ID: 23381646
[TBL] [Abstract][Full Text] [Related]
13. Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zhang R; Huang YS; Hua ZM; Yun CT; Zeng RF; Long JT
Gene; 2013 Oct; 528(2):335-42. PubMed ID: 23892089
[TBL] [Abstract][Full Text] [Related]
14. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
16. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
[TBL] [Abstract][Full Text] [Related]
17. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population.
Hu Z; Wang Y; Wang X; Liang G; Miao X; Xu Y; Tan W; Wei Q; Lin D; Shen H
Int J Cancer; 2005 Jun; 115(3):478-83. PubMed ID: 15700316
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
19. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
[TBL] [Abstract][Full Text] [Related]
20. The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.
Du H; Guo N; Shi B; Zhang Q; Chen Z; Lu K; Shu Y; Chen T; Zhu L
PLoS One; 2014; 9(5):e96301. PubMed ID: 24787743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
